SCHEDULE 13G Filed 2026-11-06 Event — SEC 0001104659-26-123999 →

Coastlands Capital LP → Bolt Biotherapeutics, Inc. BOLT

Stake: — Shares: — Class: Common Stock, par value $0.00001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

15,751 shares short · -38.8% vs prior

Other 13D/G Filings on Bolt Biotherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2022-07-15	SC	Novo Holdings A/S	—	—	view →
2021-11-22	SC	Novo Holdings A/S	—	—	view →
2021-08-13	SC	Pivotal bioVenture Partners Fund I, L.P.	—	—	view →

Other Filings by Coastlands Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-16	SCHEDULE 13G	Frazier Life Sciences Acquisition Corp. II	—	—	view →
2026-10-14	SCHEDULE 13G	iBio, Inc.	—	—	view →
2026-10-07	SCHEDULE 13G	OnKure Therapeutics, Inc.	—	—	view →
2026-10-05	SCHEDULE 13G	Pyxis Oncology, Inc.	—	—	view →
2026-07-01	SCHEDULE 13G/A	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-07-01	SCHEDULE 13G/A	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-24	SCHEDULE 13G	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-17	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →